Meet the Team

We are a team of passionate scientists and innovators committed to advancing healthcare through cutting-edge research. Our group brings together leading experts in neuroscience, neurosurgery, regulatory affairs, biomanufacturing, and business strategy—uniting the expertise needed to deliver our ground-breaking therapy to patients in need.


  • Co-Founder & CEO

    Dr. Molly Shoichet is a University Professor and Pamela & Paul Austin Chair in Precision & Regenerative Medicine at the University of Toronto. She served as Ontario’s first Chief Scientist and has been awarded numerous honors including Fellow, Royal Society (UK), Foreign Member, National Academy of Engineering (USA), and NSERC Herzberg Gold Medal – Canada’s highest award for science/ engineering. Dr. Shoichet is a passionate advocate for translational research and science communication. She is a prolific entrepreneur, with 4 spin-off companies from her lab. Dr. Shoichet is an expert in bioengineering, therapeutics delivery, and neuroregenerative of the CNS.


  • Co-founder & Operations

    Dr. Nitzan Letko Khait has completed a post-doctoral fellowship at the University of Toronto, developing an affinity release strategy for ChASE37 in pre-clinical settings of stroke injury. She earned her PhD from the Technion - Israel Institute of Technology. Dr. Letko Khait brings her expertise in drug delivery and tissue engineering.


  • Formulation & Manufacturing

    Dr. Quinton Sirianni has worked for the past 3 years as a post-doctoral fellow in the Shoichet lab, developing a biodegradable hydrogel for the sustained release of ChASE37. He earned his PhD from the University of Western Ontario. Dr. Sirianni brings his expertise in chemistry and formulation.


  • Scientist

    David Li is a PhD candidate at the University of Toronto developing genetically engineered neural stem cell therapies for CNS tissue repair following stroke in preclinical animal models. He brings his expertise in cell biology, biomaterials, and regenerative medicine.


  • Scientist

    Elisa Guo is a PhD candidate in the Shoichet lab, where her research focuses on the co-delivery of ChASE37 and neural stem cells to promote tissue regeneration following stroke in preclinical animal models. She holds a Bachelor of Science degree from the University of Waterloo and brings a strong background in molecular biology and regenerative medicine to the team.